RedHill Biopharma (RDHL) Total Non-Current Liabilities (2011 - 2026)
RedHill Biopharma (RDHL) reported Total Non-Current Liabilities of $1.79 million for the quarter ended Jun 30, 2026, up 258.4% from $500,000 a year earlier.
RedHill Biopharma (RDHL) Total Non-Current Liabilities (2011 - 2026) Analysis & Trends
As of Dec 31, 2025, RedHill Biopharma posted Total Non-Current Liabilities of $1.86 million, up 269.0% from the prior year.
- Total Non-Current Liabilities has a five-year compound annual growth rate of -54.3% (years ended Dec 2020 to Dec 2025).
- By year, Total Non-Current Liabilities came in at $503,000 in the year ended Dec 31, 2024 (-49.4%), $995,000 in the year ended Dec 31, 2023 (-89.9%), $9.82 million in the year ended Dec 31, 2022 (-88.3%) and $83.62 million in the year ended Dec 31, 2021 (-10.2%).
- Five-year quarterly Total Non-Current Liabilities spans a low of $500,000 in the quarter ended Jun 30, 2025 and a high of $200.29 million in the quarter ended Sep 30, 2022.
- Year over year, Total Non-Current Liabilities gained in two of the last four quarters, with growth averaging 111.6%.
- The high point for year-over-year Total Non-Current Liabilities in five years was the quarter ended Dec 31, 2025 (growth of 269.0%); the low point was the quarter ended Dec 31, 2023 (a decline of 89.9%).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 97.04 Bn |
| 10 | RedHill Biopharma | 1.44 Mn | -15.18 Mn | - | 1.79 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.79 Mn |
| Dec 31, 2025 | 1.86 Mn |
| Jun 30, 2025 | 500,000.00 |
| Dec 31, 2024 | 503,000.00 |
| Jun 30, 2024 | 730,000.00 |
| Dec 31, 2023 | 995,000.00 |
| Jun 30, 2023 | 3.38 Mn |
| Mar 31, 2023 | 55.20 Mn |
| Dec 31, 2022 | 9.82 Mn |
| Sep 30, 2022 | 200.29 Mn |
| Jun 30, 2022 | 13.49 Mn |
| Dec 31, 2021 | 90.84 Mn |
| Jun 30, 2021 | 94.92 Mn |
| Dec 31, 2020 | 93.14 Mn |
| Jun 30, 2020 | 95.91 Mn |
| Dec 31, 2019 | 3.48 Mn |
| Sep 30, 2019 | 17.39 Mn |
| Jun 30, 2019 | 3.74 Mn |
| Mar 31, 2019 | 14.94 Mn |
| Dec 31, 2018 | 844,000.00 |
RedHill Biopharma Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=RDHL&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "RDHL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=RDHL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();